Post RFQ
Adopts pharmaceutical grade crystallization and purification technology, strictly controls impurities and heavy metal content, complies with cGMP production specifications, has regular crystal shape and is not easy to cake, accurately matches the theoretical moisture content of heptahydrate, has no harmful residues, and can be directly used in the production of injections, external ointments and oral preparations. It solves the pain point that ordinary pharmaceutical grade magnesium sulfate has excessive impurities and cannot meet the requirements of injection grade products.
The appearance is colorless transparent monoclinic prismatic crystals, with purity ≥99.0%, moisture content 51.2%-52.0%, heavy metal (calculated as Pb) ≤5ppm, arsenic salt ≤2ppm, insoluble matter ≤0.05%, pH value 5.0-8.0, particle size 10-40 mesh, and the packaging is 25kg pharmaceutical grade composite paper bags. The production workshop is a 10,000-level clean workshop, complying with USP43 and BP2023 pharmacopoeia standards.
It is used as a raw material for clinical oral laxatives, active ingredients of external ointments for surgical swelling, raw materials of intravenous magnesium supplement preparations, excipients for veterinary pharmaceuticals, and chemical reagent raw materials for pharmaceutical research and development laboratories. It has passed EU EDQM certification and is suitable for pharmaceutical enterprises and medical research institutions.